IP Library Granted Patent US 9,920,355
Granted Patent B2
US 9,920,355 · App. 15/526,740 · Granted Mar 20, 2018

Method for fragmenting and ligating adaptors onto a nucleic acid, and kit for performing the same

Inventors: Robert Osborne (Great Chesterford, GB); Samuel Woodhouse (Cambridge, GB); Esther Musgrave-Brown (Cambridge, GB)
Assignee: POPULATION GENETICS TECHNOLOGIES LTD.
C12Q1/6806C12Q1/6869
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,920,355
App. No.
15/526,740
Granted
Mar 20, 2018
Kind
B2
Abstract

Providing herein, among other things, is a method for preparing a nucleic acid for sequencing. In some embodiments, the method comprises a) amplifying a nucleic acid template using a dNTP mix that contains 5-methyl dCTP, thereby producing product nucleic acid molecules that contains methylcytosines; b) digesting the product nucleic acid molecules with a methylation-dependent restriction endonuclease, thereby cleaving the product nucleic acid molecules at sites that are adjacent to at least some of the methylcytosine and producing fragments of the product nucleic acid molecules; and c) ligating double-stranded adaptors onto the ends of the fragments to produce adaptor-ligated products.

Claims (34)

1. A method for preparing a nucleic acid for sequencing, comprising:

a) amplifying a nucleic acid template using a dNTP mix that contains 5-methyl dCTP, thereby producing product nucleic acid molecules that contain methylcytosines;

b) digesting the product nucleic acid molecules with a MspJI family restriction endonuclease, thereby cleaving the product nucleic acid molecules at sites that are adjacent to at least some of the methylcytosines and producing fragments of the product nucleic acid molecules that contain four-base 5′ overhangs; and

c) directly ligating double-stranded adaptors onto the 5′ overhangs of the fragments to produce adaptor-ligated products.

2. The method of claim 1 , further comprising:

d) amplifying the fragments using primers that hybridize to the adaptors to produce amplification products.

3. The method of claim 1 , wherein the amplifying step a) is an isothermal amplification.

4. The method of claim 1 , wherein the amplifying step a) is by PCR.

5. The method of claim 1 , wherein the product nucleic acid molecules of a) are at least 500 bp in length.

6. The method of claim 1 , wherein the nucleic acid template is a microbial genome.

7. The method of claim 6 , wherein the microbial genome is a viral genome or a bacterial genome.

8. The method of claim 1 , wherein the nucleic acid template is a mammalian genome.

9. The method of claim 1 , wherein the amplifying step a) is done using a proof-reading polymerase.

10. The method of claim 1 , wherein the dNTP mix contains both 5-methyl dCTP and dCTP.

11. The method of claim 10 , wherein the molar ratio of 5-methyl dCTP to dCTP in the nucleotide mix is in the range of 0.01 to 99.9.

12. The method of claim 1 , wherein the double-stranded adaptors of step c) comprise a four base 5′ overhang of random sequence.

13. The method of claim 1 , wherein the restriction endonuclease is selected from the group consisting of FspEI, LpnPI, MspJI, and Sgel.

14. The method of claim 1 , wherein the digesting step b) comprises digesting the product nucleic acid molecules with a plurality of different MspJI family restriction endonucleases.

15. The method of claim 1 , wherein the fragments produced in b) are in the range of 150 bp to 1 kb in length.

16. The method of claim 1 , further comprising sequencing the adaptor-ligated products of c) or amplification products thereof.

17. The method of claim 1 , wherein the digesting and ligating occur simultaneously in the same reaction.

18. The method of claim 1 , wherein the amplification step a) is done using one or more primers that contain at least one methylcytosine.

19. A kit comprising:

a) a dNTP mix that contains at least 5-methyl dCTP;

b) one or more MspJI family restriction endonucleases; and

c) double-stranded adaptors that comprise a four-base 5′ overhang.

20. The kit of claim 19 , wherein the dNTP mix contains both 5-methyl dCTP and dCTP.

21. The kit of claim 20 , wherein the molar ratio of 5-methyl dCTP to dCTP in the nucleotide mix is in the range of 0.01 to 99.9.

22. The kit of claim 19 , further comprising a polymerase and a ligase.

23. The kit of claim 19 , wherein the polymerase is a proof-reading polymerase.

24. The kit of claim 19 , wherein the one or more MspJI family restriction endonucleases are selected from the group consisting of FspEI, LpnPI, MspJI, and Sgel.

25. The kit of claim 19 , wherein the double-stranded adaptors of c) comprise a four base 5′ overhang of random sequence.

26. The kit of claim 19 , further comprising a primer that comprises methylcytosine.

27. The method of claim 1 , wherein the method is done in the absence of nick translation.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 27, 2019
From: POPULATION GENETICS TECHNOLOGIES, LTD
To: AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH ("A*STAR")
Reel/Frame 049602/0054 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 21, 2017
From: OSBORNE, ROBERT; WOODHOUSE, SAMUEL; MUSGRAVE-BROWN, ESTHER
To: POPULATION GENETICS TECHNOLOGIES LTD.
Reel/Frame 042775/0029 →
Priority Claims (1)
GB 1421003.3 · Nov 26, 2014 · national
Continuity (1)
Related Publication 20170335371A1 · Nov 23, 2017